An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1)
Public ClinicalTrials.gov record NCT04599933. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Double-Masked, Vehicle-Controlled, Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (the NEAR-1 Study: Near Eye-vision Acuity Restoration)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 4-visit, multi-center, randomized, double-masked, vehicle-controlled study evaluating the safety and efficacy of CSF-1 in the temporary correction of presbyopia.
Study identification
- NCT ID
- NCT04599933
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 309 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 18, 2020 (Actual)
- Primary completion
- Feb 11, 2022 (Actual)
- Completion
- Feb 19, 2022 (Actual)
- Last update posted
- Apr 4, 2024
2020 – 2022
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Orasis Investigative Site | Sun City | Arizona | 85351 | — |
| Orasis Investigative Site | Glendale | California | 91204 | — |
| Orasis Investigative Site | Los Angeles | California | 90013 | — |
| Orasis Investigative Site | Fort Myers | Florida | 33901 | — |
| Orasis Investigative Site | Mt. Dora | Florida | 32757 | — |
| Orasis Investigative Site | Morrow | Georgia | 30260 | — |
| Orasis Investigative Site | Overland Park | Kansas | 66210 | — |
| Orasis Investigative Site | Louisville | Kentucky | 40206 | — |
| Orasis Investigative Site | Kansas City | Missouri | 64133 | — |
| Orasis Investigative Site | St Louis | Missouri | 63131 | — |
| Orasis Investigative Site | Henderson | Nevada | 89052 | — |
| Orasis Investigative Site | Elizabeth City | North Carolina | 27909 | — |
| Orasis Investigative Site | Cranberry Township | Pennsylvania | 16066 | — |
| Orasis Investigative Site | Wilkes-Barre | Pennsylvania | 18702 | — |
| Orasis Investigative Site | Rapid City | South Dakota | 57701 | — |
| Orasis Investigative Site | Memphis | Tennessee | 38119 | — |
| Orasis Investigative Site | El Paso | Texas | 79902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04599933, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 4, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04599933 live on ClinicalTrials.gov.